Optimizing Dried Blood Spot Sampling for Children and Adolescents With Autism Spectrum Disorder
Continued improvements in DBS quality rely on effectively addressing challenges associated with home sampling challenges, which is critical for the seamless incorporation of DBS into clinical practice.
Authors
- Birgit C. P. Koch (ORCID: https://orcid.org/0000-0002-1202-3643)
- Hacer Çetin (ORCID: https://orcid.org/0000-0002-3492-9307)
- Lisa T. Ringeling (ORCID: https://orcid.org/0000-0002-9354-6429)
- Soma Bahmany (ORCID: https://orcid.org/0000-0002-0370-0614)
- Bram Dierckx (ORCID: https://orcid.org/0000-0002-5045-9894)
- Brenda C. M. de Winter (ORCID: https://orcid.org/0000-0002-4452-8443)
- Rebecca A. Hermans (ORCID: https://orcid.org/0000-0001-9622-2246)
- Jiayi Liang (ORCID: https://orcid.org/0000-0001-5796-3412)
Institutions
- Erasmus MC (NL)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-12-15
- DOI
- https://doi.org/10.1097/ftd.0000000000001419
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00